Latest from CannIntel
Federal Appeals Court Sets Briefing Schedule for Medicare Hemp Lawsuit
The D.C. Circuit established deadlines for legal briefs in a challenge to CMS's decision to exclude hemp-derived products from Medicare coverage.
DEA Finalizes Schedule III Case in August, Marking Key Rescheduling Milestone
The agency closed its administrative record on cannabis reclassification, setting the stage for a final rule.
Pediatric Cannabis Ingestion Rate Triples Since 2000, Study Finds
New research shows unintentional recreational drug ingestions among children under six surged 1,375% over 23 years.
Marijuana Treatment Admissions Highest in States Where Cannabis Remains Illegal
New federal data shows states without legal cannabis report more drug treatment admissions for marijuana use than legal markets.
Kennesaw State Publishes THC Brain Research, Alzheimer's Drug Studies
University neuroscience team releases two peer-reviewed papers examining THC exposure effects and Alzheimer's therapeutics.
CDC Proposes Medical Cannabis Question for Federal Health Survey
The Centers for Disease Control and Prevention is seeking to add medical marijuana use to a national health tracking system.
The CannIntel legalization tracker
What growers are reading this week
Hop latent viroid is now the costliest pathogen in commercial cannabis
LED vs HPS in 2026: the calculation has changed
The germination method that consistently pops 95% of seeds
Outdoor soil prep for 2026: amend the holes, not the transplants
Trending strains right now
The CannIntel topic hubs
Strain comparisons
Best cannabis strains, by category
The cannabis glossary
The cannabis economy
Four Twenty launches Thai farm partnership with guaranteed purchases
Cannabis retailer offers cultivation contracts and technical support to local growers in Thailand market expansion.
Cannabis Consolidation Will Leave 3-5 Players Per Market, Executive Warns
Capital alone won't determine survivors — repeatable systems and hard organizational decisions separate contenders from casualties.
Cannabis Companies Gain R&D Tax Credit Access Under Rescheduling
Federal rescheduling opens IRC §41 research credit eligibility for cannabis operators previously barred by §280E.
Cannabis Firms Unlock R&D Tax Credits Under Schedule III Move
Federal rescheduling opens access to research and development credits previously barred by 280E.
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.